ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,217 | -75.2% | 2,163,473 | -4.0% | 0.00% | – |
| Q2 2023 | $1,149,757 | -14.6% | 2,254,426 | +5.5% | 0.00% | – |
| Q1 2023 | $1,346,083 | +98949.5% | 2,136,640 | +2.0% | 0.00% | – |
| Q4 2022 | $1,359 | -100.0% | 2,094,338 | +0.9% | 0.00% | -100.0% |
| Q3 2022 | $3,571,000 | +38.8% | 2,076,498 | +0.1% | 0.00% | – |
| Q2 2022 | $2,572,000 | +11.8% | 2,074,817 | -41.2% | 0.00% | – |
| Q1 2022 | $2,300,000 | -41.1% | 3,526,440 | -1.5% | 0.00% | – |
| Q4 2021 | $3,902,000 | -35.8% | 3,580,427 | +7.2% | 0.00% | -100.0% |
| Q3 2021 | $6,077,000 | -35.2% | 3,339,542 | -6.0% | 0.00% | 0.0% |
| Q2 2021 | $9,376,000 | -26.3% | 3,551,709 | +0.5% | 0.00% | -50.0% |
| Q1 2021 | $12,726,000 | +63.5% | 3,535,061 | +14.5% | 0.00% | +100.0% |
| Q4 2020 | $7,782,000 | +4.4% | 3,088,105 | +4.4% | 0.00% | 0.0% |
| Q3 2020 | $7,457,000 | -22.1% | 2,959,235 | +1.5% | 0.00% | -50.0% |
| Q2 2020 | $9,567,000 | +46.5% | 2,916,858 | +9.4% | 0.00% | 0.0% |
| Q1 2020 | $6,531,000 | -68.9% | 2,665,856 | -40.1% | 0.00% | 0.0% |
| Q4 2019 | $21,022,000 | +135.4% | 4,453,918 | +113.5% | 0.00% | 0.0% |
| Q3 2019 | $8,930,000 | -23.6% | 2,086,512 | +4.1% | 0.00% | -33.3% |
| Q2 2019 | $11,690,000 | +72.9% | 2,005,183 | +14.1% | 0.00% | +50.0% |
| Q1 2019 | $6,763,000 | +16.5% | 1,756,856 | -43.4% | 0.00% | +100.0% |
| Q4 2018 | $5,804,000 | +28.9% | 3,104,032 | +120.6% | 0.00% | 0.0% |
| Q3 2018 | $4,502,000 | +10.3% | 1,406,887 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $4,082,000 | -12.3% | 1,351,949 | +13.9% | 0.00% | -50.0% |
| Q1 2018 | $4,652,000 | -3.2% | 1,186,966 | +2.3% | 0.00% | 0.0% |
| Q4 2017 | $4,805,000 | -31.2% | 1,160,653 | +2.0% | 0.00% | -33.3% |
| Q3 2017 | $6,987,000 | +1.0% | 1,138,078 | +2.3% | 0.00% | 0.0% |
| Q2 2017 | $6,917,000 | +7.3% | 1,112,128 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $6,444,000 | +23.1% | 1,016,427 | +3.9% | 0.00% | +50.0% |
| Q4 2016 | $5,233,000 | -2.2% | 978,254 | +3.0% | 0.00% | -33.3% |
| Q3 2016 | $5,348,000 | +8.5% | 949,960 | +5.8% | 0.00% | 0.0% |
| Q2 2016 | $4,931,000 | -24.7% | 898,258 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $6,547,000 | -13.5% | 882,467 | -3.1% | 0.00% | -25.0% |
| Q4 2015 | $7,570,000 | +1.8% | 911,144 | +10.3% | 0.00% | -20.0% |
| Q3 2015 | $7,438,000 | -22.2% | 825,712 | +3.6% | 0.01% | 0.0% |
| Q2 2015 | $9,562,000 | +32.4% | 796,869 | +18.8% | 0.01% | +25.0% |
| Q1 2015 | $7,223,000 | +146.9% | 670,712 | +16.2% | 0.00% | +100.0% |
| Q4 2014 | $2,926,000 | +105.5% | 577,215 | +7.0% | 0.00% | +100.0% |
| Q3 2014 | $1,424,000 | -34.0% | 539,449 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $2,156,000 | -11.6% | 535,039 | +0.4% | 0.00% | -50.0% |
| Q1 2014 | $2,440,000 | +22.3% | 532,796 | +15.9% | 0.00% | +100.0% |
| Q4 2013 | $1,995,000 | +42.3% | 459,734 | +29.6% | 0.00% | 0.0% |
| Q3 2013 | $1,402,000 | +101.1% | 354,841 | +7.0% | 0.00% | 0.0% |
| Q2 2013 | $697,000 | – | 331,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |